Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 25.4 CHF 3.67% Market Closed
Market Cap: 146.6m CHF

Wall Street
Price Targets

XLS Price Targets Summary
Xlife Sciences AG

There are no price targets for XLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Xlife Sciences AG Competitors:
Price Targets
LAB
Standard BioTools Inc
7% Upside
PACB
Pacific Biosciences of California Inc
6% Upside
300347
Hangzhou Tigermed Consulting Co Ltd
38% Upside
EVT
Evotec SE
76% Upside
MXCT
MaxCyte Inc
304% Upside
ILMN
Illumina Inc
9% Downside
237690
ST Pharm Co Ltd
2% Downside
BRKR
Bruker Corp
2% Upside

Revenue
Forecast

Revenue Estimate
Xlife Sciences AG

For the last 4 years the compound annual growth rate for Xlife Sciences AG's revenue is 20%. The projected CAGR for the next 1 year is 157%.

20%
Past Growth
157%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Xlife Sciences AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
99%
Average Beat

Net Income
Forecast

Net Income Estimate
Xlife Sciences AG

For the last 4 years the compound annual growth rate for Xlife Sciences AG's net income is 12%.

12%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XLS's stock price target?
Not Available

XLS doesn't have any price targets made by Wall Street professionals.

What is Xlife Sciences AG's Revenue forecast?
Projected CAGR
157%

For the last 4 years the compound annual growth rate for Xlife Sciences AG's revenue is 20%. The projected CAGR for the next 1 year is 157%.

Back to Top